Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (25 Jul 2025): | 645.80 |
| Day range: | 645.80 / 645.80 |
| Change abs./rel.: | 0.00 / 0.00% |
| Year range: | 544.13 / 711.97 |
| Name | Number of shares |
|---|---|
| GALDERMA GROUP AG | 0.20249 |
| NOVO NORDISK A/S | 0.29127 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.632792 |
| GSK PLC | 1.814132 |
| NOVARTIS AG | 0.332123 |
| GENMAB A/S | 0.409759 |
| ROCHE HOLDING AG | 0.296657 |
| SANDOZ GROUP AG | 0.45607 |
| ARGENX SE | 0.210617 |
| BAYER AG | 0.591223 |
| MERCK KGAA | 0.10177 |
| ASTRAZENECA PLC | 0.465155 |
| SANOFI SA | 0.335898 |
| UCB SA | 0.430614 |
| RECORDATI SPA | 0.677898 |